Medicine and Dentistry
Melanoma
100%
Neoplasm
88%
Diseases
85%
Nonalcoholic Fatty Liver
53%
Malignant Neoplasm
44%
Lung Cancer
40%
Recurrent Disease
39%
Hemochromatosis
38%
Metastatic Carcinoma
36%
Iron
35%
Primary Biliary Cirrhosis
31%
Cancer
30%
Non Small Cell Lung Cancer
29%
Liver Transplantation
29%
Overall Survival
29%
Surgeon
27%
Liver Disease
26%
Gastroesophageal Reflux
26%
Biopsy Technique
26%
Melanoma Cell
25%
Prevalence
25%
Biological Marker
25%
Infection
25%
Melanoma Skin Cancer
25%
Breast Cancer
23%
Metastatic Melanoma
23%
Iron Overload
23%
Pneumonectomy
23%
Lung
23%
Liver Cirrhosis
22%
Endoscopy
22%
Liver Graft
21%
Messenger RNA
21%
Lobectomy
21%
Quality of Life
19%
Sphincter
18%
Health Care Cost
18%
Fibrosis
18%
Hiatus Hernia
18%
Lymph Node
18%
Primary Sclerosing Cholangitis
17%
Chronic Hepatitis B
17%
Sentinel Lymph Node
16%
Ursodeoxycholic Acid
16%
Colorectal Carcinoma
16%
Clinical Trial
16%
Nissen Fundoplication
16%
Bleeding
15%
Circulating Tumor Cell
15%
Reflux
15%
Lung Cancer Screening
14%
Immunotherapy
14%
Colonoscopy
14%
Cancer Staging
13%
Adverse Event
13%
Randomized Controlled Trial
12%
Hepatocellular Carcinoma
12%
Brain Metastasis
12%
Hepatitis B
12%
Endoscopic Retrograde Cholangiopancreatography
12%
Gastrointestinal Endoscopy
12%
Plummer-Vinson Syndrome
12%
Cholestasis
11%
Liver Biopsy
11%
Antireflux Operation
11%
Esophagus
11%
Hepatitis B Virus
11%
Reverse Transcription Polymerase Chain Reaction
11%
Pediatrics
11%
Hazard Ratio
10%
Lymphocyte
10%
Video-Assisted Thoracoscopic Surgery
10%
Colectomy
10%
Dysplasia
10%
Health Care
10%
Hepatitis C
10%
Stricture
10%
COVID-19
10%
Placebo
10%
Cell Line
10%
microRNA
10%
Lymph Duct
9%
Methylation
9%
Sentinel Node
9%
Colon Carcinoma
9%
Tumor Cell
9%
Rectum Cancer
9%
In Vitro
9%
Computer Assisted Tomography
9%
Disease
9%
Esophagectomy
9%
Reperfusion Injury
9%
Tumor Progression
9%
Neuroendocrine Tumor
9%
Liver Fibrosis
9%
Circulating microRNA
8%
Melanoma Antigen
8%
Immunohistochemistry
8%
Meta-Analysis
8%
Hepatitis B(e) Antigen
8%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
41%
Nonalcoholic Fatty Liver
38%
Diseases
37%
Melanoma
34%
Infection
27%
Primary Biliary Cirrhosis
25%
Ribavirin
25%
Iron
24%
Placebo
23%
Urea Cycle Disorder
23%
Liver Cirrhosis
21%
Adverse Event
21%
Primary Sclerosing Cholangitis
19%
Clinical Trial
19%
Chronic Hepatitis C
19%
Hepatitis C
19%
Malignant Neoplasm
19%
Ursodeoxycholic Acid
19%
Chronic Hepatitis B
18%
Sofosbuvir
17%
Liver Disease
17%
Biological Marker
16%
Prevalence
16%
Recurrent Disease
15%
Reperfusion Injury
15%
Glycerol Phenylbutyrate
15%
Hepatitis C Virus
15%
Fibrosis
15%
Hepatitis C Virus Genotype 1
13%
Hepatitis B Virus
12%
Hepatitis B
12%
Lung Cancer
12%
Messenger RNA
11%
Overall Survival
11%
Liver Cell Carcinoma
10%
Obeticholic Acid
10%
Hepatitis B(e) Antigen
9%
Interferon
9%
Hemochromatosis
9%
Cytokine
8%
Breast Cancer
8%
Non Small Cell Lung Cancer
8%
Combination Therapy
8%
Alkaline Phosphatase
8%
Inflammation
8%
Peginterferon
8%
Antiviral Drug
7%
Randomized Controlled Trial
7%
Clinical Study
7%
Cancer Staging
7%
Sodium Phenylbutyrate
7%
microRNA
7%
Alanine Aminotransferase
7%
Chemotherapy
6%
Liver Fibrosis
6%
Colorectal Carcinoma
6%
Iron Poisoning
6%
Tumor Growth
6%
Neuroendocrine Tumor
6%
Ritonavir
6%
Disease Exacerbation
6%
Circulating microRNA
6%
Chemokine
6%
Olipudase Alfa
6%
Sphingomyelin Phosphodiesterase
6%
Pruritus
6%
Lymph Node Metastasis
6%
Ischemia
6%
Ledipasvir Plus Sofosbuvir
5%
Phenylacetic Acid
5%
Cutaneous Melanoma
5%
Gastroesophageal Reflux
5%
Ledipasvir
5%
Alpha Tocopherol
5%
Comorbidity
5%
Interleukin 4
5%
Hepcidin
5%
Tumor Necrosis Factor
5%
Pharmacokinetics
5%
Disease Free Survival
5%
Cholestasis
5%
Biochemistry, Genetics and Molecular Biology
Genomics
26%
Genetics
24%
Epigenetics
23%
Methylation
23%
Blood Plasma
21%
DNA Methylation
20%
Urea Cycle Disorder
17%
Overall Survival
16%
Iron Poisoning
16%
Iron Overload
16%
MicroRNA
16%
Messenger RNA
11%
Clinical Trial
10%
Carcinogenesis
10%
Tumor Progression
10%
Prevalence
9%
Promoter Region
9%
Loss of Heterozygosity
9%
T Cell
8%
Cancer Cell
8%
Allele
8%
Haplotype
8%
Autosomal Recessive Inheritance
8%
Genotyping
8%
Gene Expression
8%
Cancer Screening
7%
Wild Type
7%
Reperfusion
6%
Ferritin Blood Level
6%
Genetic Screening
6%
Enzyme
6%
Cohort Study
6%
Iron Storage
6%
Oxidative Stress
5%
Upregulation
5%
Glycerol
5%
Cancer Staging
5%
Alkaline Phosphatase
5%
Hepcidin
5%
Pan-cancer
5%
Colon
5%
Phlebotomy
5%
Tubulin
5%
Estrogen Receptor
5%
Tumor Suppressor Gene
5%
Hepatitis C Virus
5%
HFE (Gene)
5%
Multivariate Analysis
5%
Genetic Divergence
5%
RNA
5%
Ornithine Transcarbamylase Deficiency
5%